molecular genetic technique
molecular genetic technique is a genetic therapy with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
50.0%
2 of 4 finished
50.0%
2 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
DNA Variations in the Gene in Young Patients With Wilms' Tumor
Clinical Trials (8)
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
DNA Variations in the Gene in Young Patients With Wilms' Tumor
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
Pharmacokinetics of Dactinomycin in Young Patients With Cancer
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
All 8 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 8